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Abstract
Background: Benzylisoquinoline is the structural backbone of many alkaloids with a wide variety of structures
including papaverine, noscapine, codeine, morphine, apomorphine, berberine, protopine and tubocurarine. Many
benzylisoquinoline alkaloids have been reported to show therapeutic properties and to act as novel medicines.
Thus it is important to collect and compile benzylisoquinoline alkaloids in order to explore their usage in medicine.
Description: We extract information about benzylisoquinoline alkaloids from various sources like PubChem, KEGG,
KNApSAcK and manual curation from literature. This information was processed and compiled in order to create a
comprehensive database of benzylisoquinoline alkaloids, called BIAdb. The current version of BIAdb contains
information about 846 unique benzylisoquinoline alkaloids, with multiple entries in term of source, function leads
to total number of 2504 records. One of the major features of this database is that it provides data about 627
different plant species as a source of benzylisoquinoline and 114 different types of function performed by these
compounds. A large number of online tools have been integrated, which facilitate user in exploring full potential
of BIAdb. In order to provide additional information, we give external links to other resources/databases. One of
the important features of this database is that it is tightly integrated with Drugpedia, which allows managing data
in fixed/flexible format.
Conclusions: A database of benzylisoquinoline compounds has been created, which provides comprehensive
information about benzylisoquinoline alkaloids. This database will be very useful for those who are working in the
field of drug discovery based on natural products. This database will also serve researchers working in the field of
synthetic biology, as developing medicinally important alkaloids using synthetic process are one of important
challenges. This database is available from http://crdd.osdd.net/raghava/biadb/.
Background
Alkaloids are naturally occurring secondary metabolites,
low molecular weight, and nitrogen containing com-
pounds that are found in more than 20% of plant spe-
cies [1]. A plant contains more than 0.01% of alkaloids
is called alkaloid plants [2-4]. They show pharmacologi-
cal effects and are being commonly used as medicines
(e.g., analgesic as morphine). Alkaloids are biologically
significant and can act as stimulators, inhibitors and
growth terminators [5,6]. They also have anti-microbial
and anti-parasitic properties [7-14]. Alkaloids can alter
DNA, selectively deform cells and cause locoism. Nowa-
days, non-natural alkaloids are growing rapidly as a
result of bioorganic and stereochemistry research.
Pharmacological research and the drug industry rapidly
advance and promote the most promising new mole-
cules for possible production applications [15].
Alkaloids can be classified on the basis of biological
activities, chemical structure and biosynthetic pathways.
Following are few of major classes of alkaloids; (i) Pyr-
rolidine: is an organic compound with the molecular
formula C4H9N; (ii) Quinoline: is a heterocyclic aro-
matic organic compound with formula C9H7N; (iii)
Benzylisoquinoline: is a heterocyclic aromatic organic
compound & structural isomer of quinoline; (iv) Indole:
is an aromatic heterocyclic organic compound (v) Ter-
penoid: a diverse class of naturally occurring organic
chemicals. The benzylisoquinoline alkaloid (BIA) is a
diverse category of alkaloids including berberine,
morphine, sanguinarine, hydrastine and many more.
Alkaloids belonging to this class are found to be
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properties. Recent studies suggested that these alkaloids
could be considered as novel medicines [2]. For exam-
ple, the magnoflorine has been reported to protect HDL
during oxidant stress [16-18]. A recent report stated
that anti-microbial agent berberine had cholesterol-low-
ering activity [19]. Tetrandrine (TET) is a bis-benzyliso-
quinoline alkaloid, which is identified as an active
ingredient in Radix Stephanae tetrandrae (a Chinese
medicinal herb). It has been used traditionally for the
treatment of congestive circulatory disorder and inflam-
matory diseases [20].
Best of authors’ knowledge there is no databases of
BIA molecules, which are very important from medicine
point of view. In order to facilitate researchers working
in the field of drug discovery/design, we made a sys-
tematic attempt in this study to collect and compile BIA
molecules. This database is user-friendly and equipped
with powerful computational tools like Jmol [21]. BIAdb
also has provision for searching the chemical com-
pounds against this database on the basis of structural
similarity.
Construction and content
BIAdb Resources
BIAdb contains; (i) comprehensive information about
BIA’s, (ii) tools for 2-dimensional and 3-dimensional
structure visualization, (iii) hyperlinks to related data-
bases, and (iv) tools for searching structurally similar
molecules. BIAdb contains manually curated data as
well as from different sources like public databases
[22-25]. Total 846 unique BIAs have been incorporated
into the database till date. The statistics of the data has
been shown in Table 1.
Data Structure
The BIAdb database contains the following fields for
each benzylisoquinoline alka l o i de n t r y ;( 1 )n a m e ;( 2 )
PubChemID; 3) KEGG ID; (4) source; (5) type; (6) func-
tion; (7) molecular weight; (8)exact mass; (9) molecular
formula; (10) XLogP; (11) Topological Polar Surface
Area (TPSA); (12) IUPAC name; (13) H-bond donors;
(14) H-bond acceptors; (15) number of rotatable bonds;
(16) canonical smile; (17) isomeric smile; (18) structure
(sdf, mol, pdb) file;(19) pubmed web-link; and (20) link
to Drugpedia.
Organization of Data
The whole data of BIA’s compounds was organized in
four different ways, these are physio-chemical proper-
ties, sources, functions and clustering of whole data was
done using standalone version of LibraryMCS software.
The organization of data on the basis of physio-chemical
properties can be retrieve through the browse option
provided in the web server. The data has been organized
according to the different ranges of the molecular
weight, XLogP, TPSA of BIA’s.
The whole data was clustered using the standalone
LibraryMCS v0.7 from ChemAxon. LibraryMCS clusters
a set of chemical structures on a structural basis. Struc-
tures that share a common substructure are clustered
together. The clustering program identifies the common
substructure, and it is always the largest one among all
substructures found in the structure set. Such substruc-
ture is called the Maximum Common Substructure
(MCS). The clustering technique applied in LibraryMCS
is hierarchical, that is, clusters of input structures are
grouped into second level clusters, and then these sec-
ond level clusters are grouped again and so on, until a
termination condition is reached.
The matching parameters for clustering were atom
type, bond type, charge, hybridization and isotopes,
minimum cluster size. Performance of LibraryMCS soft-
ware depends upon various factors like average structure
size, diversity, minimal required MCS size and atom/
bond constraints.
The file containing structural information of all 846
compounds was given as input to the software using
minimum cluster size 7 under normal speed. Librar-
yMCS generated 14 top-level clusters and total of 87
clusters with four levels of hierarchy. Figure 1 shows the
LibraryMCS clustering report.
The data was grouped according to the top-level clus-
ters. The groups were named Group 1 to Group 14
each containing different number of input compounds.
Table 2 Indicates the total number of compounds in
each of 14 top level clustered groups obtained using
LibraryMCS software.
Utility
Web Tools
Apart from the data collected about benzylisoquinoline
alkaloids, a variety of tools has been implemented within
the database to enhance the scope of database. Follow-
ing are the main web tools integrated in BIAdb.
Keyword Search and Advanced search
A simple text search tool is provided for searching on
selected fields of database. The advance search option
Table 1 Number of unique BIA molecules from different
data sources
DATA SOURCE NUMBER OF ENTRIES
KEGG (COMPOUNDS & DRUGS) 196
Comparative Toxicogenomics Database (CTD) 145
PubChem 171
Other Sources (literature search) 334
TOTAL 846
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Using this option, users can search BIA’sc o m p o u n d s
within a range of value of physiochemical properties and
retrieve corresponding results.
The browsing tool provides the options to the user to
select particular range of compounds on the basis of
their physio-chemical properties like molecular weight,
XLogP and TPSA.
Structure visualization and similarity Search
A simple Java based JME (Java Molecular Editor) [26] tool,
has been provided to draw structure to be searched in the
database using JC search tool [27]. The tool provides sub-
structure, exact, super structure, perfect and simple
searching options. Figure 2 depict the structure search
tool provided in the database. BIAdb facilitates the users
to display 2-D and 3-D structure of molecules using Jmol.
User is provided with many options to visualize the struc-
ture in many different ways. Figure 3 represents the van
der Waals surface representation of morphine.
Figure 1 LibraryMCS clustering report. Figure shows a clustering result of BIA’s Compounds, Top level show a cluster of compounds at four
different levels, left side shows the cluster id, number of compounds in a cluster and the base structure use for clustering. Right side shows the
output in the form of input file, time taken for clustering, cluster level, top level cluster and total number of cluster.
Table 2 Number of compounds in 14 Top level clusters
obtained from LibraryMCS
GROUPS ID Number of Compounds
in each cluster
Group 1 920 394
Group 2 922 127
Group 3 919 120
Group 4 921 102
Group 5 923 90
Group 6 924 3
Group 7 925 2
Group 8 926 2
Group 9 927 1
Group 10 928 1
Group 11 929 1
Group 12 930 1
Group 13 931 1
Group 14 932 1
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BIAdb also has the facility to add more entries related
to benzylisoquinoline alkaloids by the users. The user
can add new compound information with in specified
fields (the fields with star are mandatory) and entries
will be then added to the database after proper
validation.
Drugpedia
BIAdb provides a Drugpedia [28] link corresponding to
each single entry. Data hosted in BIAdb platform follow
a definite pattern. Therefore, to provide more flexibility
to different kinds of data a Drugpedia link would be
beneficial, where user can update or add any relevant
information. The important and relevant information
from Drugpedia page may be included in the main data-
base frame after processing and validation, during the
updating of BIAdb. Figure 4 illustrates a typical Drugpe-
dia page for BIAdb 1-Benzylisoquinoline 1022.
Data Flow
Text search option operates on data type like BIA’s
name e.g. “morphine”. The advance search page pro-
vides variety of options to query the database. User can
use data types like name of the compound, molecular
weight, XLogP, Polar Surface Area ranges. Query search
term “morphine” retrieves number of entries related to
Figure 2 Structure search tool in BIAdb. An example of a structure drawn in JME and search against BIAdb by selecting substructure search,
using JC search tool.
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entry to retrieve the detailed information about the
“morphine”. The two-dimensional as well as three-
dimensional structures of morphine can be visualized by
clicking 2-D & 3-D structure buttons in the 2-D & 3-D
structure field. In addition to this user can also down-
load the structure coordinates file in different format
like SDF, MOL, and PDB by a clicking on their respec-
tive field. Figure 5 depicts the knowledge flow in BIAdb.
Web Interface and Application
LAMP (Linux-Apache-Mysql-PHP), an open source
software has been used to create the database. PHP,
HTML and CSS technologies have been used to build
t h ed y n a m i cw e bi n t e r f a c e .M y S Q L ,ar e l a t i o n a ld a t a -
base management system (RDBMS), works at the back-
end. Server-side scripting makes use of PHP. The
whole software system runs on IBM SAS x3800
machine under Red Hat Enterprise Linux 5 environ-
ment using Apache httpd server. PHP and MySQL
combination is quite efficient and powerful for data-
base management.
Figure 3 Structure of Morphine visualized by Jmol. Structure of
the morphine visualized by Jmol, in ball-sticks model representing
the van der Waals suface, showing different labels of atoms; white
balls are hydrogen atom, red oxygen, yellow sulphur, blue nitrogen
and gray are carbon atoms.
Figure 4 Drugpedia page of BIAdb 1-Benzylisoquinoline 1022. Figure shows a Drugpedia page for BIAdb 1-Benzylisoquinoline 1022. Top
right corner contains link for new account creation and login. For searching a search option is provided in the middle left. To edit, discuss, or
see history of a particular page, links are embedded on top left of the page.
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Page 5 of 8Figure 5 Knowledge flow in BIAdb.D a t af l o wf o rB I A ’sh a v eb e e ns h o w ni nd i f f e r e n tc o l o rs c h e m es; red colored fields show search tool,
orange color shows browse tools, blue color shows link to other databases, green color depict the data fields and sky blue color structure
search tool.
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BIAdb is a comprehensive information portal of benzyli-
soquinoline alkaloids. User can search important infor-
mation regarding the BIA’sa n dc a na l s ov i e wt h e
structures of the compounds. This database will definitely
be of great use for researchers. BIAdb is developed keep-
ing in mind the general user requirement. Thus searching
and exploring the database is easy and convenient.
Further, this information can be used to design analogs
of BIA’s, which can act as potential drug candidates.
Conclusion
BIAdb is a webserver of an important class of alkaloids
called benzylisoquinoliones which facilitate users to do
extensive search. This database encapsulates important
information about BIA’s compounds regarding their
source and medicinal values. The structure search facil-
ity will be helpful for users in finding compounds simi-
lar to BIA’s. The online submission facility will be
helpful for expanding this database. This resource will
be helpful for those working in the field of drug design-
ing to explore their role as potential drug molecules.
Limitations and future prospects
Our major limitation in developing the database is that the
information about benzylisoquinoline alkaloids is very less
and too scattered. Lot of literature search is required to
further expand the database. In order to maintain the
database dynamically without losing any information
about BIA’s, we make the multiple records in term of dif-
ferent source and function performed by a compounds. In
near future, we are hopeful of expanding the database
both qualitatively as well as quantitatively to cover the
synthesis pathways of these BIA’s and to include the syn-
thetic parts available to shorten the synthesis process and
to increase the yield. This database will be updated manu-
ally as soon as enough data will be available.
Availability and requirements
BIAdb is available at http://crdd.osdd.net/raghava/biadb/
and its mirror site http://www.imtech.res.in/raghava/
biadb. To access BIAdb World Wide Web is a pre-
requisite. To access all features of BIAdb to its optimum
level, JavaScript and Java Runtime Environment (JRE)
plugin must be enabled.
List of abbreviations used
BIA: Benzylisoquinoline Alkaloids; CTD: Comparative Toxicogenomics
Database; PHP: Hypertext Preprocessor language; HTML: Hypertext Markup
Language; CSS: Cascading Style Sheet.
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